Aceclofenac 100mg + Paracetamol 325mg + Caffeine 25mg + Cetirizine 10mg + Phenylephrine 5mg Tablets – Product Overview

Aceclofenac 100mg + Paracetamol 325mg + Caffeine 25mg + Cetirizine 10mg + Phenylephrine 5mg Tablets are a multi-ingredient pharmaceutical formulation containing five active pharmaceutical ingredients in a single solid dosage form. Each tablet contains Aceclofenac 100mg, Paracetamol 325mg, Caffeine 25mg, Cetirizine 10mg, and Phenylephrine 5mg.

The formulation is developed through pharmaceutical formulation techniques that allow multiple active ingredients with different physical and chemical characteristics to be incorporated into one tablet. Such combination formulations require careful consideration of ingredient compatibility, excipient selection, manufacturing processes, and quality-control parameters.

The development of this type of tablet involves controlled stages including raw-material selection, dispensing, blending, granulation or other suitable processing, compression, inspection, quality testing, and packaging. Maintaining consistency across every stage is essential for achieving a uniform finished product.

Active Pharmaceutical Ingredients & Formulation

This formulation combines Aceclofenac 100mg, Paracetamol 325mg, Caffeine 25mg, Cetirizine 10mg, and Phenylephrine 5mg in a single tablet. The presence of multiple active ingredients makes formulation development an important part of product manufacturing.

Each ingredient has its own physical and chemical properties, including differences in particle size, flow behavior, solubility, stability, and compatibility. Formulation scientists therefore evaluate these characteristics before finalizing the composition and manufacturing process.

Suitable pharmaceutical excipients may be incorporated to support powder flow, blending, granulation, tablet compression, stability, and other physical properties. The objective is to achieve a consistent distribution of all five active ingredients throughout the manufacturing batch.

During formulation development, parameters such as content uniformity, tablet hardness, friability, disintegration, and overall physical appearance may be evaluated. Appropriate formulation optimization helps establish a reproducible manufacturing process.

Manufacturing & Quality Control

The production of Aceclofenac 100mg + Paracetamol 325mg + Caffeine 25mg + Cetirizine 10mg + Phenylephrine 5mg Tablets requires systematic manufacturing and quality-control procedures.

The process generally begins with the procurement and testing of pharmaceutical-grade active ingredients and excipients. Approved raw materials are then dispensed according to the specified formulation and processed under controlled manufacturing conditions.

Depending on the selected production method, stages may include sifting, blending, granulation, drying, lubrication, compression, and tablet inspection. Appropriate in-process controls can be implemented to monitor parameters such as blend uniformity, moisture, tablet weight, hardness, thickness, and appearance.

Finished-product testing may include evaluation of assay, content uniformity, average weight, weight variation, hardness, friability, disintegration, and other applicable specifications. Since five active ingredients are present in the same formulation, analytical testing should be capable of accurately assessing the individual components.

Proper batch documentation and traceability are also important parts of pharmaceutical manufacturing. These records support quality management and allow individual production batches to be monitored throughout their lifecycle.

Tablet Characteristics & Product Development

Multi-ingredient tablets require careful attention to formulation compatibility and manufacturing consistency. Aceclofenac 100mg + Paracetamol 325mg + Caffeine 25mg + Cetirizine 10mg + Phenylephrine 5mg Tablets bring together five different active pharmaceutical ingredients, making formulation design particularly important.

During development, pharmaceutical scientists may evaluate the compatibility of each active ingredient with the selected excipients. Stability assessments can also be performed to understand how the formulation behaves under defined storage conditions.

The physical characteristics of the tablet are another important consideration. Parameters such as tablet weight, thickness, hardness, friability, appearance, and disintegration can be assessed during formulation development and routine production.

Uniform distribution of all active ingredients is essential for maintaining the defined composition of the finished dosage form. Controlled blending and appropriate processing conditions help support this requirement.

A well-developed combination tablet therefore requires a balance between ingredient compatibility, manufacturing efficiency, physical stability, and consistent quality attributes.

Packaging & Product Presentation

Packaging helps protect Aceclofenac 100mg + Paracetamol 325mg + Caffeine 25mg + Cetirizine 10mg + Phenylephrine 5mg Tablets during storage, transportation, and distribution. Suitable pharmaceutical packaging is selected according to the formulation characteristics and applicable packaging requirements.

Primary packaging is designed to provide an appropriate protective environment for the tablets, while secondary packaging supports product identification, handling, and transportation.

Accurate labeling is particularly important for a multi-ingredient formulation. The packaging generally identifies the product name, composition, individual strengths, batch number, manufacturing information, expiry details, manufacturer information, and other applicable regulatory particulars.

A professional packaging design can also contribute to pharmaceutical brand recognition. Consistent colors, typography, layouts, and labeling formats across different products can help create a well-organized pharmaceutical portfolio.

Pharmaceutical Portfolio & Quality-Focused Approach

Aceclofenac 100mg + Paracetamol 325mg + Caffeine 25mg + Cetirizine 10mg + Phenylephrine 5mg Tablets can form part of a diversified pharmaceutical product portfolio containing combination formulations and different dosage forms.

For pharmaceutical manufacturers, distributors, franchise businesses, and marketing organizations, combination products can contribute to a broader and more structured product range. However, specialized formulations require appropriate manufacturing expertise and quality-control systems to maintain consistency.

A quality-focused approach begins with the selection of pharmaceutical-grade raw materials and continues through formulation development, controlled manufacturing, analytical testing, packaging, storage, and distribution. Maintaining documented procedures at every stage helps support batch-to-batch consistency.

For this five-ingredient formulation, particular attention can be given to active-ingredient uniformity, formulation compatibility, tablet characteristics, analytical testing, stability, packaging integrity, and batch traceability.

Overall, the development of Aceclofenac 100mg + Paracetamol 325mg + Caffeine 25mg + Cetirizine 10mg + Phenylephrine 5mg Tablets involves advanced formulation planning and controlled pharmaceutical manufacturing. Appropriate ingredient selection, optimized formulation design, systematic quality testing, professional packaging, and reliable production processes all contribute to developing a consistent and quality-focused finished pharmaceutical product.